Cargando…

Streptococcus agalactiae from Ethiopian pregnant women; prevalence, associated factors and antimicrobial resistance: alarming for prophylaxis

BACKGROUND: Maternal Streptococcus agalactiae (Group B Streptococcus, GBS) colonization rates and its antibiotic resistance patterns provide important information useful in guiding prevention strategies. There is a paucity of evidence about GBS in the Amhara National Regional State, Ethiopia. OBJECT...

Descripción completa

Detalles Bibliográficos
Autores principales: Gizachew, Mucheye, Tiruneh, Moges, Moges, Feleke, Adefris, Mulat, Tigabu, Zemene, Tessema, Belay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339690/
https://www.ncbi.nlm.nih.gov/pubmed/30660188
http://dx.doi.org/10.1186/s12941-019-0303-3
_version_ 1783388670742495232
author Gizachew, Mucheye
Tiruneh, Moges
Moges, Feleke
Adefris, Mulat
Tigabu, Zemene
Tessema, Belay
author_facet Gizachew, Mucheye
Tiruneh, Moges
Moges, Feleke
Adefris, Mulat
Tigabu, Zemene
Tessema, Belay
author_sort Gizachew, Mucheye
collection PubMed
description BACKGROUND: Maternal Streptococcus agalactiae (Group B Streptococcus, GBS) colonization rates and its antibiotic resistance patterns provide important information useful in guiding prevention strategies. There is a paucity of evidence about GBS in the Amhara National Regional State, Ethiopia. OBJECTIVE: To determine colonization prevalence, associated risk factors, and antibiotics resistance including inducible clindamycin resistance patterns of GBS among Ethiopian pregnant women. METHODS: A prospective cross-sectional study was conducted from 1st December 2016 to 30th November 2017 at the University of Gondar Referral hospital delivery ward. Combined recto-vaginal swabs were collected from 385 pregnant women and analyzed at the University of Gondar Bacteriology Laboratory by using LIM broth and 5% defibrinated sheep blood agar culture methods. Isolates were identified by using colony morphology, gram reaction, hemolysis, and CAMP test. Antibiotic susceptibility test was done using the disc diffusion method. Double disc diffusion method was used to identify inducible clindamycin resistance isolates. Data were analyzed by SPSS version 20 software. p ≤ 0.05 was considered as statistically significant. RESULTS: The overall prevalence of maternal GBS colonization was 25.5% (95% CI 21–29.5%). Experiencing meconium stained amniotic fluid (AOR = 3.018, 95% CI 1.225, 7.437), and longer duration of premature rupture of membrane (AOR = 1.897, 95% CI 1.014, 3.417) were statistically significant to maternal colonization. Furthermore, GBS resistant to 0 (8.2%), 1 (25.5%) and 3 (39.8%) or more antibiotics were identified. A D-test showed 15.2% inducible clindamycin resistant GBS. Constitutive macrolide lincosamide–streptogramin(B), L-, and M-phenotypes were also detected. CONCLUSIONS: Maternal GBS colonization rate in this study was higher compared to the previous reports in Ethiopia. This much prevalence and antibiotics resistance results are the clue to which attention shall be given to this bacterium during management of pregnant women and the newborns.
format Online
Article
Text
id pubmed-6339690
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63396902019-01-24 Streptococcus agalactiae from Ethiopian pregnant women; prevalence, associated factors and antimicrobial resistance: alarming for prophylaxis Gizachew, Mucheye Tiruneh, Moges Moges, Feleke Adefris, Mulat Tigabu, Zemene Tessema, Belay Ann Clin Microbiol Antimicrob Research BACKGROUND: Maternal Streptococcus agalactiae (Group B Streptococcus, GBS) colonization rates and its antibiotic resistance patterns provide important information useful in guiding prevention strategies. There is a paucity of evidence about GBS in the Amhara National Regional State, Ethiopia. OBJECTIVE: To determine colonization prevalence, associated risk factors, and antibiotics resistance including inducible clindamycin resistance patterns of GBS among Ethiopian pregnant women. METHODS: A prospective cross-sectional study was conducted from 1st December 2016 to 30th November 2017 at the University of Gondar Referral hospital delivery ward. Combined recto-vaginal swabs were collected from 385 pregnant women and analyzed at the University of Gondar Bacteriology Laboratory by using LIM broth and 5% defibrinated sheep blood agar culture methods. Isolates were identified by using colony morphology, gram reaction, hemolysis, and CAMP test. Antibiotic susceptibility test was done using the disc diffusion method. Double disc diffusion method was used to identify inducible clindamycin resistance isolates. Data were analyzed by SPSS version 20 software. p ≤ 0.05 was considered as statistically significant. RESULTS: The overall prevalence of maternal GBS colonization was 25.5% (95% CI 21–29.5%). Experiencing meconium stained amniotic fluid (AOR = 3.018, 95% CI 1.225, 7.437), and longer duration of premature rupture of membrane (AOR = 1.897, 95% CI 1.014, 3.417) were statistically significant to maternal colonization. Furthermore, GBS resistant to 0 (8.2%), 1 (25.5%) and 3 (39.8%) or more antibiotics were identified. A D-test showed 15.2% inducible clindamycin resistant GBS. Constitutive macrolide lincosamide–streptogramin(B), L-, and M-phenotypes were also detected. CONCLUSIONS: Maternal GBS colonization rate in this study was higher compared to the previous reports in Ethiopia. This much prevalence and antibiotics resistance results are the clue to which attention shall be given to this bacterium during management of pregnant women and the newborns. BioMed Central 2019-01-19 /pmc/articles/PMC6339690/ /pubmed/30660188 http://dx.doi.org/10.1186/s12941-019-0303-3 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Gizachew, Mucheye
Tiruneh, Moges
Moges, Feleke
Adefris, Mulat
Tigabu, Zemene
Tessema, Belay
Streptococcus agalactiae from Ethiopian pregnant women; prevalence, associated factors and antimicrobial resistance: alarming for prophylaxis
title Streptococcus agalactiae from Ethiopian pregnant women; prevalence, associated factors and antimicrobial resistance: alarming for prophylaxis
title_full Streptococcus agalactiae from Ethiopian pregnant women; prevalence, associated factors and antimicrobial resistance: alarming for prophylaxis
title_fullStr Streptococcus agalactiae from Ethiopian pregnant women; prevalence, associated factors and antimicrobial resistance: alarming for prophylaxis
title_full_unstemmed Streptococcus agalactiae from Ethiopian pregnant women; prevalence, associated factors and antimicrobial resistance: alarming for prophylaxis
title_short Streptococcus agalactiae from Ethiopian pregnant women; prevalence, associated factors and antimicrobial resistance: alarming for prophylaxis
title_sort streptococcus agalactiae from ethiopian pregnant women; prevalence, associated factors and antimicrobial resistance: alarming for prophylaxis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339690/
https://www.ncbi.nlm.nih.gov/pubmed/30660188
http://dx.doi.org/10.1186/s12941-019-0303-3
work_keys_str_mv AT gizachewmucheye streptococcusagalactiaefromethiopianpregnantwomenprevalenceassociatedfactorsandantimicrobialresistancealarmingforprophylaxis
AT tirunehmoges streptococcusagalactiaefromethiopianpregnantwomenprevalenceassociatedfactorsandantimicrobialresistancealarmingforprophylaxis
AT mogesfeleke streptococcusagalactiaefromethiopianpregnantwomenprevalenceassociatedfactorsandantimicrobialresistancealarmingforprophylaxis
AT adefrismulat streptococcusagalactiaefromethiopianpregnantwomenprevalenceassociatedfactorsandantimicrobialresistancealarmingforprophylaxis
AT tigabuzemene streptococcusagalactiaefromethiopianpregnantwomenprevalenceassociatedfactorsandantimicrobialresistancealarmingforprophylaxis
AT tessemabelay streptococcusagalactiaefromethiopianpregnantwomenprevalenceassociatedfactorsandantimicrobialresistancealarmingforprophylaxis